Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy-induced alopecia].

Dominique Spaëth1, Nathalie Rosso, Laetitia Clivot

  • 1Centre d'oncologie de Gentilly, 54100 Nancy.

La Revue Du Praticien
|February 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study.

Oncology letters·2025
Same author

Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe).

JNCI cancer spectrum·2024
Same author

Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohort.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).

PloS one·2023
Same author

Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.

Clinical breast cancer·2023
Same author

Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.

European urology·2023

Chemotherapy can cause hair loss, but scalp cooling may help prevent it for certain treatments. More research is needed to confirm the long-term safety and effectiveness of these hair loss prevention methods.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Context:

  • Chemotherapy-induced alopecia (CIA) is a common and distressing side effect of many cancer treatments.
  • Existing prevention strategies for CIA are limited in efficacy and scope.

Purpose:

  • To review the mechanisms and evolution of chemotherapy-induced alopecia.
  • To describe current and emerging prevention tools for chemotherapy-induced alopecia.
  • To evaluate the efficacy and safety of scalp cooling and pharmacological interventions.

Summary:

  • Scalp cooling systems, including helmets and continuous cooling devices, show potential in mitigating or preventing hair loss for specific chemotherapy regimens.
  • While scalp cooling may be effective, patient tolerance can be variable, and long-term harmlessness requires further investigation through prospective studies.

Related Experiment Videos

  • Pharmacological approaches for preventing chemotherapy-induced alopecia are still in the early stages of research and development.

    • Impact:

    • Provides a comprehensive overview of chemotherapy-induced alopecia, aiding clinicians in managing patient expectations and treatment side effects.
    • Highlights the potential of scalp cooling as a viable option for hair loss prevention during chemotherapy, improving patient quality of life.
    • Identifies the need for further research into both scalp cooling safety and novel drug-based prevention strategies for chemotherapy-induced alopecia.